Navigation Links
Ambit Biosciences Announces Third Quarter 2013 Operating Results
Date:11/7/2013

SAN DIEGO, Nov. 7, 2013 /PRNewswire/ -- Ambit Biosciences (NASDAQ: AMBI), a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced third quarter and year-to-date operating results for 2013.  The company will host a conference call today to discuss financial results for the third quarter and year-to-date, and to provide an operational update on developments in the quarter.

"We are pleased to have made good progress toward our goals during the third quarter, moving forward in the development of our lead drug candidate, quizartinib.  We are excited about the upcoming events at ASH in December, where we will have the opportunity to present data from our most recent studies," said Michael Martino, Ambit's president and Chief Executive Officer. "As we head into the last quarter of 2013, we are looking forward to feedback from our upcoming FDA meeting in November and we will provide an update on our development and regulatory plans for quizartinib following that meeting.  Additionally, we remain on track to start our Phase 3 trial in early-2014, as previously guided."

Operational Update
The Company is pleased to announce the acceptance of four abstracts with preliminary data highlighting the Company's lead drug candidate, quizartinib.  Presentations of the final data and two additional posters will be presented during the ASH 55th Annual Meeting at the Ernest Morial Convention Center in New Orleans, LA on December 9, 2013.  Oral presentations include the following:

Results of Phase 2 Randomized, Open-Label, Study of Lower Doses of Quizartinib in Subjects with FLT3-ITD Positive Relapsed Acute Myeloid Leukemia (AML):  The purpo
'/>"/>

SOURCE Ambit Biosciences
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Ambit Announces Participation At 12th Annual BIO Investor Forum
2. Ambit Announces Participation At The BioCentury NewsMakers in the Biotech Industry Conference
3. Ambit Announces Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the Annual Meeting of the American Society of Clinical Oncology
4. Ambit Biosciences Files Registration Statement for Proposed Initial Public Offering
5. APAC Stem Cell Research & Therapy Market a “Growth Engine” for Region’s Scientific Ambitions Says A New Market Research Report at ReportsnReports.com
6. Astellas and Ambit Announce Data Presentations Highlighting Quizartinib at the American Society of Hematology 54th Annual Meeting
7. Ambit Biosciences to Present at Two Upcoming Investor Conferences
8. Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society
9. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
10. Pressure BioSciences, Inc. Reports Third Quarter 2013 Financial Results and Provides Business Update
11. Juneau Biosciences Names Dr. Dinesh Patel to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... CAMBRIDGE, Mass. , July 22, 2014 /PRNewswire/ ... of $650 million from philanthropist Ted Stanley ... disorders and bringing new treatments based on molecular ... the world. The Stanley commitment ... among the largest for scientific research in general ...
(Date:7/22/2014)... New Jersey , 22. Juli 2014 /PRNewswire/ ... die Life-Sciences-Industrie, hat die Ernennung von Marcus Bergler ... bekanntgegeben. Herr Bergler hat die europäischen kommerziellen Aktivitäten ... unterstützt. Bevor er sich Qforma anschloss, war er ... Cegedim Customer Information, als Vertriebsteam-Leiter Deutschland bei IMS ...
(Date:7/21/2014)... 2014 Lawrence Livermore National ... (WIB) and Las Positas College (LPC) recently established ... and hands-on training for veterans, officials recently announced. ... Las Positas is designed to help veterans ... technician careers, and establishes a pipeline of qualified ...
(Date:7/21/2014)... The yield so far is small, but chemists ... solution-based mineral substitution process to make a precursor to ... and alternative energy devices. , A paper describing the ... 21 issue of the journal Inorganic Chemistry , ... inorganic and nuclear chemistry fields. The paper was chosen ...
Breaking Biology Technology:$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 2$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 3$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 4$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 5$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 6$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 7$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 8$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 9$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 10Qforma gibt Schaffung des neuen Postens als General Manager in Europa bekannt 2Engineering Program Established for Veterans 2Engineering Program Established for Veterans 3Oregon chemists eye improved thin films with metal substitution 2
... Analysts are ... only 308 job cuts announced in the pharmaceutical industry in March, 27,000 new health care ... be correct. , ... -- If the absence of bad news can be considered good news, then it is good ...
... Encyclopedia ... Amazon.com , ... (PRWEB) April 15, 2010 -- The preponderance of autism research shows no correlation between vaccines ... encyK Resource for Parents & Professionals . By retracting the article that first reported the ...
... , ... by Behavioral HealthCare Program to streamline data reporting and ad hoc analysis , ... (PRWEB) April 13, 2010 ... utilizes a complex relational database for storing its data. The program manages behavioral ...
Cached Biology Technology:The MedZilla Report for April 2010 - Pharma Layoffs Drop Below 400 in March; Health Care Adds Another 27,000 Jobs 2The MedZilla Report for April 2010 - Pharma Layoffs Drop Below 400 in March; Health Care Adds Another 27,000 Jobs 3Research in Autism Encyclopedia Shows No Link to Children With Autism, Supports Lancet Retraction 2Maine Medical Center Chooses Business Intelligence Solution from Rapid Insight Inc. 2
(Date:7/22/2014)... a cost-effectiveness analysis of commercial diet programs and pills, ... the best value for the money. The Jenny Craig ... the most expensive option tested, according to researchers at ... The findings, published in the June issue of the ... health and weight-loss benefits per dollar spent as insurance ...
(Date:7/22/2014)... MSN, APRN, PMHCNS-BC, CNE, Assistant Professor of Clinical ... School of Nursing, contributed samples used in a ... with schizophrenia and also suggesting a possible link ... Biological insights from 108 schizophrenia-associated genetic loci, was ... , available at http://www.nature.com/nature/journal/vaop/ncurrent/full/nature13595.html., ...
(Date:7/22/2014)... 22, 2014 NXT-ID, Inc., (NXTD: OTCQB) a biometric ... announces its next generation smart wallet, Wocket™, will be featured ... show that airs on the History Channel, FYI ... regularly features top technology products and services. The ... History Channel (6:00-6:30am ET/PT) and the FYI Network ...
Breaking Biology News(10 mins):Study compares cost-effectiveness of weight-loss programs and drugs 2Study compares cost-effectiveness of weight-loss programs and drugs 3LSUHSC contributes to work identifying new DNA regions associated with schizophrenia 2NXT-ID's Next Generation Wocket Smart Wallet to be Featured on NewsWatch, Airing on History Channel, FYI Network and ION Network 2NXT-ID's Next Generation Wocket Smart Wallet to be Featured on NewsWatch, Airing on History Channel, FYI Network and ION Network 3
... Indiana University study found that strengthening inspiratory muscles by ... the amount of oxygen these same breathing muscles required ... muscles. Louise Turner, a researcher in the Department ... an endurance activity, such as running, swimming or cycling ...
... to all living things can make hibernating marmots hungry ... obesity and eating disorders, according to a new study ... appears in the current issue of the Journal ... at http://jeb.biologists.org/cgi/reprint/213/12/2031 . Professor Greg Florant discovered ...
... dish coating could overcome a major challenge to the ... of Michigan researchers. Under today,s regulations, current stem ... the cells have been grown on animal-based substances that ... components create issues with the FDA (the U.S. Food ...
Cached Biology News:Inspiratory muscle training and endurance sport performance 2Marmots can teach us about obesity 2New culture dish could advance human embryonic stem cell research 2
CleanCut agarose is used to prepare genomic DNA plugs for use in pulsed field gel electrophoresis (PFGE) applications. Supplied as a 12 ml solution of 2% agarose....
... 96 PW is an intelligent full microplate washer ... wells simultaneously. This instrument gives you the best ... washing efficiency , Performance ,Separate ... excellent wash efficiency. A dispense precision of better ...
... for cell culture scale-up, these culture chambers ... - 10 9 range and are ... spinner flasks. • High mechanical • strength ... prior to shipping • Certified nonpyrogenic and ...
... in immunostaining ,This solution has effect on ... get clearer signal than the one obtained ... amount of secondary antibody used and exposure ... can have images with high S/N ratio ...
Biology Products: